Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia.
about
Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Experience with ibrutinib for ...... chronic lymphocytic leukemia.
@en
Experience with ibrutinib for ...... chronic lymphocytic leukemia.
@nl
type
label
Experience with ibrutinib for ...... chronic lymphocytic leukemia.
@en
Experience with ibrutinib for ...... chronic lymphocytic leukemia.
@nl
prefLabel
Experience with ibrutinib for ...... chronic lymphocytic leukemia.
@en
Experience with ibrutinib for ...... chronic lymphocytic leukemia.
@nl
P2860
P356
P1476
Experience with ibrutinib for ...... chronic lymphocytic leukemia.
@en
P2093
Jennifer R Brown
P2860
P356
10.1177/2040620717741861
P577
2017-11-28T00:00:00Z